Cogan's syndrome: An autoimmune inner ear disease

Autoimmunity Reviews

Volumn 12, Issue 3, 2013, Pages 396-400

  Greco, A ^a   Gallo, A ^a   Fusconi, M ^a   Magliulo, G ^a   Turchetta, R ^a   Marinelli, C ^a   Macri, G F ^a   De Virgilio, A ^a   de Vincentiis, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aetiopathogenesis; Anti neutrophil cytoplasmic auto antibody; Autoimmune inner ear diseases; Autoimmunity; Cogan's syndrome; Therapy; Vasculitis

Indexed keywords

ANTIGEN; AUTOANTIBODY; CD148 ANTIGEN; COGAN PEPTIDE; CONNEXIN 26; CORNEA ANTIBODY; ENDOTHELIAL CELL ANTIBODY; ETANERCEPT; IMMUNOGLOBULIN G; INFLIXIMAB; INNER EAR ANTIBODY; LYMPHOCYTE ANTIGEN; METHYLPREDNISOLONE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANTIBODY TITER; AUTOIMMUNITY; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; COGAN SYNDROME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INNER EAR; LYMPHOCYTE ACTIVATION; MENIERE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REVIEW; VASCULITIS; VIRUS INFECTION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COGAN SYNDROME; HUMANS; LABYRINTH DISEASES;

EID: 84872399259     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.07.012     Document Type: Review

References (66)

1. Cogan D. Syndrome of non-syphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 1945, 33:144-149.
2. Cody D.T.R., Williams H.L. Cogan's syndrome. Laryngoscope 1960, 70:447-475.
3. Cundiff J., Kansal S., Kumar A., Goldstein D.A., Tessler H.H. Cogan's syndrome: a cause of progressive hearing deafness. Am J Otolaryngol 2006, 27:68-70.
4. Vollertsen R.S., McDonald T.J., Younge B.R., Banks P.M., Stanson A.W., Ilstrup D.M. Cogan's syndrome: 18 cases and a review of the literature. Mayo Clin Proc 1986, 61:344-361.
5. Haynes B.F., Kaiser-Kupfer M.I., Mason P., Fauci A.S. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine 1980, 59:426-441.
6. Cheson B.D., Bluming A.Z., Alroy J. Cogan's syndrome: a systemic vasculitis. Am J Med 1976, 60:549-555.
7. Vollersten R. Vasculitis and Cogan's syndrome. Rheum Dis Clin North Am 1990, 16:433-438.
8. McCallum R.M., Allen N.B., Cobo L.M., Weber B.A., Haynes B.F. Cogan's syndrome: clinical features and outcomes. Arthritis Rheum 1992, 35(Suppl.):S51.
9. Scully R.E., Mark E.J., McNeely W.F., Ebeling S.H. Weekly clinicopathological exercises. N Engl J Med 1999, 340:635-641.
10. Ferrari E., Taillan B., Garnier G., Dor V., Morand P., Dujardin P. Manifestations cardiovasculaires du syndrome de Cogan. A propos d'un cas. Arch Mal Coeur 1992, 85:913-916.
11. Bicknell J.M., Holland J.V. Neurologic manifestations of Cogan's syndrome. Neurology 1978, 28:278-281.
12. Chynn E.W., Jacobiec F.A. Cogan's syndrome: ophthalmic, audiovestibular, and systemic manifestations and therapy. Int Opthalmol Clin 1996, 36:61-72.
13. Thomas H.G. Case report: clinical and radiological features of Cogan's syndrome non-syphilitic interstitial keratitis, audiovestibular symptoms and systemic manifestations. Clin Radiol 1992, 45:418-421.
14. Ho A.C., Roat M.I., Venbrux A., Hellmann D.B. Cogan's syndrome with refractory aortitis and mesenteric vasculitis. J Rheumatol 1999, 26:1404-1407.
15. Van Doornum S., McColl G., Walter M., Jennens I., Bhathal P., Wicks I.P. Prolonged prodrome, systemic vasculitis, and deafness in Cogan's syndrome. Ann Rheum Dis 2001, 60:69-71.
16. Casselman J.W., Majoor M.H., Albers F.W. MR of the inner ear in patients with Cogan syndrome. AJNR Am J Neuroradiol 1994, 15:131-138.
17. Broughton S.S., Meyerhoff W.E., Cohen S.B. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum 2004, 34:544-548.
18. Gluth M.B., Baratz K.H., Matteson E.L., Driscoll C.L. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 2006, 81:483-488.
19. Raza K., Karokis D., Kitas G.D. Cogan's syndrome with Takayasu's arteritis. Br J Rheumatol 1998, 37:369-372.
20. St.Clair E.W., McCallum R.M. Cogan's syndrome. Curr Opin Rheumatol 1999, 11:47-52.
21. Darougar S., John A.C., Viswalingam M., Cornell L., Jones B.R. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with otological and cardiovascular lesions. Br J Ophthalmol 1978, 62:709-714.
22. Jones B.R. Trachoma and allied diseases of the eye. Trans Ophthalmol Soc U K 1961, 81:367-378.
23. Jones B.R. Ocular syndromes of TRIC-virus infection and their possible genital significance. Br J Vener Dis 1964, 40:3-18.
24. Lancet, Editorial Chlamydiae and genital infection. Lancet 1973, l:703.
25. Lancet, Editorial Chlamydial infections of the eye. Lancet 1977, 2:857-858.
26. Ostler H.B., Schachter J., Dawson C.R. Acute follicular conjunctivitis of epizootic origin. Arch Ophthalmol 1969, 82:587-591.
27. Schachter J., Arnstein P., Dawson C.R., Hanna L. Human follicular conjunctivitis caused by infection with a psittacosis agent. Proc Soc Exp Biol Med 1968, 127:292-295.
28. Ljungstrom L., Franzen C., Schlaug M., Elowson S., Viidas U. Reinfection with Chlamydia pneumoniae may induce isolated and systemic vasculitis in small and large vessels. Scand J Infect Dis 1997, 104(Suppl.):37-40.
29. Ikeda M., Okazaki H., Minota S. Cogan's syndrome with antineutrophil cytoplasmic autoantibody. Ann Rheum Dis 2002, 61:761-762.
30. Majoor M.H.J.M., Albers F.W.J., Van Der Gaag R., Gmelig-Meyling F., Huizing E.H. Corneal autoimmunity in Cogan's syndrome? Report of two cases. Ann Otol Rhinol Laryngol 1992, 101:679-684.
31. Pouchot J., Vinceneux P., Bouccara D., Sterkers O., Bodelet B. Methotrexate as a steroid-sparing agent in Cogan's syndrome: comment on the concise communication by Richardson. Arthritis Rheum 1995, 38:1348.
32. Ben Taarit C., Turki S., Chaabouni L., Moalla M., Ben Maiz H. Association d'un syndrome de Cogan et d'une polyarthrite rheumatoid. Rev Med Interne 1996, 17:860-861.
33. Froehlich F., Fried M., Gonvers J.J., Saraga E., Thorens J., Pecoud A. Association of Crohn's disease and Cogan's syndrome. Dig Dis Sci 1994, 39:1134-1137.
34. Brinkman C.J., Broekhuyse R.M. Cell-mediated immunity after retinal detachment as determined by lymphocyte stimulation. Am J Ophthalmol 1978, 86:260-265.
35. Hughes G.B., Kinney S.E., Barna B.P., Tomsak R.L., Calabrese L.H. Autoimmune reactivity in Cogan's syndrome: a preliminary report. Arch Otolaryngol Head Neck Surg 1983, 91:24-32.
36. Peeters G.J., Cremers C.W., Pinckers A.J., Hoefnagels W.H.L. Atypical Cogan's syndrome: an autoimmune disease?. Ann Otol Rhinol Laryngol 1986, 95:173-175.
37. Lunardi C., Bason C., Leandri M., Navone R., Lestani M., Millo E., et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002, 360:915-921.
38. Schuknecht H.F. Ear pathology in autoimmune diseases. Adv Otorhinolaryngol 1991, 46:50-70.
39. Fisher E.R., Hellstrom H.R. Cogan's syndrome and systemic vascular disease. Arch Pathol 1961, 72:96-116.
40. McCabe B.F. Autoimmune sensorineural hearing loss. Ann Otol 1979, 88:585-589.
41. Bonaguri C., Orsoni J.G., Zavota L., Monica C., Russo A., Pellistri I., et al. Anti-68 kDa antibodies in autoimmune sensorineural hearing loss: are these autoantibodies really a diagnostic tool?. Autoimmunity 2007, 40:73-78.
42. Jennette J.C., Falk R.J. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990, 15:517-529.
43. Lochman I., Kral V., Lochmanova A., Lupac J., Cebecauer L. ANCA in the diagnosis of neutrophil-mediated inflammation. Autoimmun Rev 2011, 10:295-298.
44. Falk R.J., Terrell R., Charles L.A., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals. Proc Natl Acad Sci U S A 1990, 87:4115-4119.
45. Tervaert J.W.C., Mulder L., Stegeman C., Elema J., Huitema M., The H., et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993, 52:115-120.
46. Yamanishi Y., Ishioka S., Takeda M., Maeda H., Yamakido M. Atypical Cogan's syndrome associated with antineutrophil cytoplasmic autoantibodies. Br J Rheumatol 1996, 35:601-603.
47. Brijker F., Magee C.C., Tervaert J.W., O'Neill S., Walshe J.J. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol 1999, 52:344-351.
48. Lepse N., Abdulahad W.H., Kallenberg C.G., Heeringa P. Immune regulatory mechanisms in ANCA-associated vasculitides. Autoimmun Rev 2011, 11:77-83.
49. García Berrocal J.R., Vargas J.A., Ramírez-Camacho R.A., González F.M., Gea-Banacloche J.C., et al. Deficiency of naive T cells in patients with sudden deafness. Arch Otolaryngol Head Neck Surg 1997, 123:712-717.
50. Dornhoffer J.L., Arenberg J.G., Arenberg I.K., Shambaugh G.E. Pathophysiological mechanisms in immune inner ear disease. Acta Otolaryngol 1997, 256(Suppl.):30-36.
51. Ghadban R., Couret M., Zenone T. Efficacy of Infliximab in Cogan's Syndrome. J Rheumatol 2008, 35:2456-2458.
52. García Berrocal J.R., Vargas J.A., Vaquero M., Ramón y Cajal S., Ramírez-Camacho R.A. Cogan's syndrome: an oculoaudiovestibular disease. Postgrad Med J 1999, 75:262-264.
53. Pleyer U., Baykal H.E., Rohrbach J.M., Bohndorf M., Rieck P., Reimann J., et al. Cogan I syndrome: too often detected too late? A contribution to early diagnosis of Cogan I syndrome. Klin Monbl Augenheilkd 1995, 207:3-10.
54. Migliori G., Battisti E., Pari M., Vitelli N., Cingolani C. A shifty diagnosis: Cogan's syndrome. A case report and review of the literature. Acta Otorhinolaryngol Ital 2009, 29:108-113.
55. Allen N.B., Cox C.C., Cobo M., Kisslo J., Jacobs M.R., McCallum R.M., et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. Am J Med 1990, 88:296-301.
56. Riente L., Taglione E., Berrettini S. Efficacy of methotrexate in Cogan's syndrome. J Rheumatol 1996, 23:1830-1831.
57. Touma Z., Nawwar R., Hadi U., Hourani M., Arayssi T. The use of TNF-alpha blockers in Cogan's syndrome. Rheumatol Int 2007, 27:995-996.
58. Weyn T., Haine S., Conraads V. Cogan's syndrome with left main coronary artery occlusion. Cardiol J 2009, 16:573-576.
59. Fricker M., Baumann A., Wermelinger F., Villiger P.M., Helbling A. A novel therapeutic option in Cogan disease? TNF-alpha blockers. Rheumatol Int 2007, 27:493-495.
60. Matteson E.L., Choi H.K., Poe D.S., Wise C., Lowe V.J., McDonald T.J., et al. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center open-label, pilot study. Arthritis Rheum 2005, 53:337-342.
61. Alcântara C., Gomes M.J., Ferreira C. Rituximab therapy in primary Sjögren's syndrome. Ann N Y Acad Sci 2009, 1173:701-705.
62. Dønvik K.K., Omdal R. Churg-Strauss syndrome successfully treated with rituximab. Rheumatol Int 2011, 31:89-91.
63. Golay J., Lazzari M., Facchinetti V., Bernasconi S., Borleri G., Barbui T., et al. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. Blood 2001, 98:3383-3389.
64. Orsoni J.G., Laganà B., Rubino P., Zavota L., Bacciu S., Mora P. Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report. Orphanet J Rare Dis 2010, 16:5-18.
65. Bobbio Pallavicini F., Caporali R., Sarzi-Puttini P., Atzeni F., Bazzani C., Gorla R., et al. Tumor necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry. Autoimmun Rev 2010, 9:175-180.
66. Ben-Ami E., Berrih-Aknin S., Miller A. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev 2011, 10:410-415.